[
    "{\"step_by_step_thinking\": \"Avelumab is a type of immunotherapy drug known as a checkpoint inhibitor. It works by blocking a protein called PD-L1 on the surface of certain cells in the immune system. This allows the immune system to recognize and attack cancer cells. Urothelial carcinoma is a type of bladder cancer. Avelumab has been shown in clinical trials to be effective in treating urothelial carcinoma.\", \"answer_choice\": \"A\"}"
]